As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Cathie Wood’s Ark Invest recently sold over 550,000 shares of UiPath (NYSE:PATH). The stock is down 16% so far this year.

Canadian investors could consider owning beaten-down AI stocks such as AMD to generate outsized gains in the next 12 months.

UiPath, a leading enterprise automation and AI software company, has announced its annual UiPath Agentic AI Summit will take ...

UiPath to hold Agentic AI Summit on March 25 to demonstrate its latest agentic automation innovations and how UiPath ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

Zurcher Kantonalbank Zurich Cantonalbank grew its stake in UiPath Inc. (NYSE:PATH – Free Report) by 57.5% in the 4th quarter, ...

Steward Partners Investment Advisory LLC grew its position in shares of UiPath Inc. (NYSE:PATH – Free Report) by 99.8% during ...

UiPath (NYSE: PATH) reported quarterly financial results that disappointed stock market investors. Start Your Mornings ...

UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.

BMO Capital analyst Keith Bachman lowered the firm’s price target on UiPath (PATH) to $11.50 from $16 and keeps a Market Perform rating on the ...

UiPath (NYSE:PATH) saw its stock plummet over 14% intra-day today after delivering a disappointing revenue forecast for ...